US Broker Ratings

Integra LifeSciences Holdings C (IART): Investor Outlook with a 20% Upside Potential

Integra LifeSciences Holdings Corporation (NASDAQ: IART) stands at an intriguing juncture for investors, presenting a compelling opportunity for those looking to capitalize on its potential upside..

Liquidia Corporation (LQDA) Stock Analysis: Unveiling a 46% Upside Potential in the Biopharmaceutical Arena

Liquidia Corporation (NASDAQ: LQDA), a dynamic player in the healthcare sector, is making waves in the biopharmaceutical industry with its innovative approach to treating rare cardiopulmonary..

The Pennant Group, Inc. (PNTG) Stock Analysis: Healthcare Growth with a 14% Upside Potential

The Pennant Group, Inc. (NASDAQ: PNTG), a prominent player in the healthcare sector, is drawing attention from investors due to its robust growth metrics and promising..

MannKind Corporation (MNKD) Stock Analysis: Unpacking the 137.87% Potential Upside

MannKind Corporation (MNKD) is capturing the attention of investors with a compelling investment proposition. As a prominent player in the biotechnology sector, MannKind has carved a..

Aveanna Healthcare Holdings Inc (AVAH) Investor Outlook: Analyzing a 15% Potential Upside

Aveanna Healthcare Holdings Inc (AVAH), an integral player in the U.S. healthcare sector, has captured investor interest with its robust revenue growth and a promising potential..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 58% Potential Upside in the Biotech Sector

Investors in the biotech sector should keep a keen eye on MiMedx Group, Inc. (NASDAQ: MDXG), a company specializing in the development and distribution of placental..

ANI Pharmaceuticals, Inc. (ANIP)

⚠️ No article content returned.

..

Clover Health Investments (CLOV): Exploring a 24% Upside Potential with a Strong Revenue Growth Story

Clover Health Investments, Corp. (NASDAQ: CLOV) stands as a noteworthy player in the healthcare sector, specifically within the healthcare plans industry. With a strong focus on..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 66% ROE and Promising Analyst Ratings

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stands out in the biotechnology sector with its focus on developing therapies for autoimmune diseases with significant unmet needs. Headquartered in..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A Promising 19.93% Upside in the Booming Mental Health Sector

Investors eyeing opportunities in the healthcare sector might find LifeStance Health Group, Inc. (NASDAQ: LFST) an intriguing candidate. With a market capitalization of $4.5 billion, LifeStance..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Evaluating a Potential 89% Upside in Biotech Innovation

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a burgeoning name in the biotechnology sector, has been capturing attention with its innovative approach to tackling cardiorenal conditions. As a..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Exploring a 32.86% Upside Potential

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV), a leading player in the development and sale of buprenorphine-based prescription drugs, has been drawing attention from investors due to its..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector with a 2.92% Upside

Azenta, Inc. (NASDAQ: AZTA) presents a compelling opportunity for investors looking to capitalize on steady growth within the healthcare sector. Specializing in medical instruments and supplies,..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Unpacking a 12.67% Upside Potential for Investors

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, particularly in the medical care facilities industry, has captured the attention of investors..

agilon health, inc. (AGL) Stock Analysis: Navigating a 48.79% Upside Potential in Healthcare

Investors with a keen eye on the healthcare sector may find agilon health, inc. (NYSE: AGL) a compelling opportunity, as the company navigates the complex landscape..

ImmunityBio, Inc. (IBRX) Stock Analysis: A 49.65% Potential Upside Driven by Innovative Immunotherapies

ImmunityBio, Inc. (NASDAQ: IBRX) stands at the intersection of biotechnology innovation and investor interest, with a market cap of $9.03 billion. This San Diego-based company operates..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating the Potential Despite a -33.56% Downside Projection

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, has carved out a significant niche in the medical devices industry. Specializing in cutting-edge..

Apogee Therapeutics (APGE): Investor Outlook on a $10.22 Billion Biotech Pioneer

In the dynamic world of biotechnology, Apogee Therapeutics, Inc. (NASDAQ: APGE) stands out as a formidable player, with an impressive market capitalization of $10.22 billion. Based..

Ocular Therapeutix (OCUL): Investor Outlook Reveals 253.90% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing the attention of investors with its promising pipeline in the biotechnology sector. Specializing in innovative ophthalmic therapies, this Bedford,..

Envista Holdings Corporation (NVST) Stock Analysis: A 26.42% Potential Upside in the Dental Healthcare Sector

Envista Holdings Corporation (NYSE: NVST) is a key player in the healthcare sector, specializing in medical instruments and supplies, particularly in the dental industry. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds